Back to AMLN Stock Lookup

AMLN Related Analyst Comments

Jul 2, 2012 03:10 PM Barclays on AstraZeneca (AZN): Acquisition of AMLN Makes Strategic Sense but High Price Tag

Jun 19, 2012 07:38 AM Jefferies Says FDA Request from Amylin (AMLN) Will Not Impact Acquisition Potential

Jun 15, 2012 09:09 AM Amylin (AMLN) Wants a Buyout Price At Least in the Low-to-Mid $30s - Jefferies

Apr 20, 2012 10:05 AM Canaccord Genuity on Biotechnology: Q1 Earnings Preview - What To Expect

Apr 5, 2012 08:10 AM Jefferies Raises Numbers on Amylin Pharmaceuticals (AMLN) On Upside to Bydureon Sales

Mar 28, 2012 12:35 PM Analysts Expecting Higher Bids for Amylin (AMLN)

Mar 28, 2012 11:06 AM Baird Comments on Amylin (AMLN) On Takeover Speculation

Mar 12, 2012 09:07 AM Collins Stewart maintains a 'Sell' on Amylin Pharmaceuticals (AMLN); Bydureon Now Has 2% Market Share

Feb 7, 2012 07:40 AM Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance

Jan 30, 2012 02:52 PM Analyst Sees Increased Chance of Amylin (AMLN) Takeover Amid Bydureon Approval

Jan 30, 2012 11:28 AM Goldman Sachs Keeps "Sell" on Amylin (AMLN) Despite FDA Approval

Jan 30, 2012 08:59 AM Baird maintains an 'Outperform' on Amylin Pharmaceuticals (AMLN); Bydureon Approval Huge Positive, Removes Major Downside Risk

Jan 30, 2012 07:25 AM Jefferies Maintains a 'Buy' on Amylin Pharmaceuticals (AMLN); FDA Approves Bydureon With Strong Label

Jan 25, 2012 08:10 AM Jefferies Says Amylin Pharmaceuticals (AMLN) Undervalued With Pending Ex-US Partnership for Exenatide

Jan 4, 2012 11:12 AM Goldman Sachs Highlights Best and Worst in Biotech for 2012

Nov 9, 2011 02:34 PM Barclays Maintains an 'Equalweight' on Eli Lilly (LLY); Removal of Legal Overhang Allows for Increased Flexibility on Existing Pipeline

Nov 9, 2011 01:23 PM Jefferies Comments on Alkermes (ALKS) Partnership Spilt with Eli Lilly (LLY) and Amylin (AMLN)

Nov 8, 2011 01:17 PM Leerink Says Terminated Alliance with Lilly Opens Doors for M&A at Amylin (AMLN)

Oct 20, 2011 07:37 AM Baird Maintains a 'Neutral' on Amylin Pharmaceuticals (AMLN); Q3-11: Continued Revenue Stabilization and a New Indication for Byetta

Sep 19, 2011 12:20 PM Jefferies Comments on Amylin Pharmaceuticals (AMLN) Following EASD Diabetes Meeting

Jul 27, 2011 12:48 PM Jefferies Raises Price Target on Amylin Pharmaceuticals (AMLN), Bydureon Back on Track

Jul 8, 2011 09:14 AM Jefferies Comments on Amylin (AMLN) Following tQT Results; Sees Approval in Q112

Jul 8, 2011 08:28 AM Jefferies Sees Amylin's (AMLN) Bydureon Receiving FDA Approval Following Positive QT Study Results

Jun 27, 2011 10:22 AM Jefferies Comments on Amylin Pharm. (AMLN) Following Solid News at ADA

Mar 17, 2011 10:48 AM Canaccord Genuity Morning Coffee on Amylin Pharma (AMLN): Fat Chance of Approval?

Jan 27, 2011 01:55 PM Barclays Maintains an 'Equalweight' on Amylin Pharmaceuticals (AMLN); Solid 4Q, TQT Questions Persist

Jan 27, 2011 09:01 AM Jefferies Raises Estimates on Amylin Pharmaceuticals (AMLN), Maintains Buy Rating

Jan 18, 2011 01:51 PM Barclays Maintains an 'Equalweight' on Amylin Pharmaceuticals (AMLN); Management Meeting - TQT Trial Update

Oct 20, 2010 12:01 PM Wave of Downgrades Hits Amylin, Alkermes, Eli Lilly (AMLN, ALKS, LLY)

Sep 24, 2010 08:06 AM Deutsche Bank Maintains a 'Buy' on Amylin Pharmaceuticals (AMLN); Thinking Long-Term: Bydureon a Likely Blockbuster

Aug 31, 2010 01:07 PM Barclays Maintains an 'Overweight' Rating on Amylin Pharmaceuticals (AMLN); TRx Share Continues to Increase Byetta Losing Share in GLPs

Jul 19, 2010 09:25 AM Citi Maintains a 'Buy' on Amylin Pharmaceuticals (AMLN); Trimming PT Due to Higher Bydureon COGS

Jul 12, 2010 12:14 PM Leerink Swann Says M&A Is One Reason To Get Involved In Biophama (AGN, DNDN, BMRN, HGSI, more...)

Jun 18, 2010 08:15 AM Piper Jaffray Said Taspo Delays A Positive for Amylin (AMLN)

May 27, 2010 10:26 AM Citi Announces Highlights from Recent Healthcare Conference

Jan 26, 2010 09:32 AM Jefferies & Co Maintains a 'Buy' on Amylin Pharmaceuticals (AMLN); Raises PT

Jan 26, 2010 09:22 AM Canaccord Adams Said Novo Approval Is Negative for Amylin (AMLN)

Jan 20, 2010 03:38 PM Amylin Pharmaceuticals (AMLN) Sees Upside Action

Dec 24, 2009 08:06 AM Leerink Says FDA OK of Once a Week Byetta Could Be Delayed Til Year-End '10, But Raises Price Target on Amylin (AMLN)

Nov 11, 2008 11:02 AM Canaccord Adams Maintains 'Hold' Rating on Amylin Pharmaceuticals (AMLN), Lowers Price Target

Sep 2, 2008 11:40 AM Canaccord Adams Reiterates Sell on Amylin (AMLN)

Aug 27, 2008 01:00 PM Wall Street Throws In the Towel On Amylin (AMLN) Following New Byetta Patient Deaths

Aug 27, 2008 10:42 AM Canaccord Adams Lowers Price Target on Amylin (AMLN) to $20

Aug 21, 2008 10:21 AM Goldman Removes Amylin (AMLN) from Conviction Buy List; Maintains Buy

Aug 19, 2008 12:53 PM Canaccord Reiterates Sell on Amylin (AMLN) Following Byetta Issues

Aug 19, 2008 08:48 AM Piper Jaffray Believes the Street Overreacted to Amylin's (AMLN) Pancreatitis Update

Jul 22, 2008 08:31 AM Amylin Pharma (AMLN) Added To Goldman Sachs Conviction Buy List; Gilead (GILD) Removed

Apr 1, 2008 09:00 AM Piper Jaffray Adds Amylin Pharma. (AMLN) to Alpha List

Nov 19, 2007 09:10 AM Piper Jaffray Adds Amylin Pharmaceuticals (AMLN) to the Alpha List

Jul 24, 2007 08:56 AM Goldman Sachs adds Amylin Pharmaceuticals (AMLN) to its Conviction Buy List

Back to AMLN Stock Lookup